Skip links and keyboard navigation

Staff photography changes outlook on radiation bunker

18 May 2017

The treatment rooms in the Princess Alexandra Hospital’s (PAH) Radiation Department have had a makeover thanks to the photographic talents of past and present staff.

The Radiation Oncology Department called for photographic submission, which staff and patients then voted on.

Retired Director of Physics Dr John Doody stood out among the crowd and five of his images were enlarged to hang.

Dr Margot Lehman, Director of Radiation Oncology, said the images were now the first thing patients would see as they walk into the treatment room (known as the radiation bunker) for their daily radiation treatments.

“It can be very daunting for patients to walk into the bunker, especially for the first time,” she said.

“We hoped that seeing a beautiful image would help to ease patient anxiety and create a welcoming and comforting environment.”

Dr Lehman said patients’ responses had been very positive with many commenting on the beauty of the images.

“In a clinical environment, there is always a place for art and beauty and reminders of the wonders of nature,” she said.

John Doody was now spending his retirement travelling and is in demand as a photographic judge for competitions throughout Queensland.

Last updated 19 May 2017
Last reviewed 19 May 2017

Other news

Bowel cancer early detection is key

Bowel Cancer—early detection is key

Bowel cancer is Australia’s second biggest cancer killer but is one of the most treatable types if found early. This Bowel Cancer Awareness Month Princess Alexandra Hospital Health Promotion Officer Abby Fraser was encouraging the community to ‘Make No. 2 your No. 1 priority’ and participate in the free National Bowel Cancer Screening Program.

Dr Darshan Shah clot dissolving drug trial for stroke patients

Trial tests time-saving clot-dissolving drug

A clot-dissolving drug trial could see stroke patients receive life-saving treatment faster. The Princess Alexandra Hospital Stroke Unit was participating in a trial that aimed to show Tenecteplase, a clot-dissolving drug currently used in heart attack patients, could reduce treatment time for stroke patients by an hour.